M&T Bank’s Quest Diagnostics DGX Stock Holding History

M&T Bank’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.59M	Sell	13,200 -1,774	-12%	-$345K	0.01%	537
2025 Q4	$2.6M	Buy	14,974 +2,218	+17%	+$404K	0.01%	559
2025 Q3	$2.43M	Sell	12,756 -1,542	-11%	-$274K	0.01%	536
2025 Q2	$2.57M	Buy	14,298 +109	+0.8%	+$18.9K	0.01%	547
2025 Q1	$2.4M	Sell	14,189 -888	-6%	-$146K	0.01%	554
2024 Q4	$2.27M	Buy	15,077 +3,420	+29%	+$532K	0.01%	625
2024 Q3	$1.81M	Sell	11,657 -1,015	-8%	-$152K	0.01%	718
2024 Q2	$1.73M	Buy	12,672 +327	+3%	+$44.8K	0.01%	699
2024 Q1	$1.64M	Buy	12,345 +2,352	+24%	+$305K	0.01%	726
2023 Q4	$1.38M	Buy	9,993 +2,483	+33%	+$326K	0.01%	764
2023 Q3	$916K	Buy	7,510 +52	+0.7%	+$6.93K	﹤0.01%	869
2023 Q2	$1.05M	Sell	7,458 -893	-11%	-$123K	﹤0.01%	855
2023 Q1	$1.18M	Buy	8,351 +1,438	+21%	+$206K	﹤0.01%	798
2022 Q4	$1.08M	Sell	6,913 -1,157	-14%	-$166K	﹤0.01%	822
2022 Q3	$990K	Sell	8,070 -167	-2%	-$22K	﹤0.01%	835
2022 Q2	$1.06M	Sell	8,237 -23,111	-74%	-$3.15M	0.01%	755
2022 Q1	$4.29M	Sell	31,348 -514	-2%	-$71.6K	0.02%	394
2021 Q4	$5.51M	Buy	31,862 +3,759	+13%	+$572K	0.02%	369
2021 Q3	$4.08M	Buy	28,103 +38	+0.1%	+$5.56K	0.02%	417
2021 Q2	$3.71M	Buy	28,065 +5,024	+22%	+$658K	0.02%	440
2021 Q1	$2.96M	Buy	23,041 +2,284	+11%	+$281K	0.01%	468
2020 Q4	$2.47M	Buy	20,757 +1,137	+6%	+$139K	0.01%	522
2020 Q3	$2.25M	Sell	19,620 -1,166	-6%	-$138K	0.01%	501
2020 Q2	$2.37M	Buy	20,786 +1,179	+6%	+$125K	0.01%	478
2020 Q1	$1.57M	Buy	19,607 +8,212	+72%	+$850K	0.01%	588
2019 Q4	$1.22M	Sell	11,395 -605	-5%	-$63.1K	0.01%	554
2019 Q3	$1.28M	Buy	12,000 +683	+6%	+$70.1K	0.01%	647
2019 Q2	$1.15M	Sell	11,317 -101	-0.9%	-$9.71K	0.01%	685
2019 Q1	$1.03M	Sell	11,418 -2,940	-20%	-$255K	0.01%	711
2018 Q4	$1.2M	Buy	14,358 +480	+3%	+$45K	0.01%	628
2018 Q3	$1.5M	Sell	13,878 -2,414	-15%	-$265K	0.01%	625
2018 Q2	$1.79M	Sell	16,292 -5,541	-25%	-$577K	0.01%	579
2018 Q1	$2.19M	Sell	21,833 -8,415	-28%	-$862K	0.01%	519
2017 Q4	$2.98M	Sell	30,248 -1,263	-4%	-$120K	0.02%	446
2017 Q3	$2.95M	Buy	31,511 +3,768	+14%	+$400K	0.02%	453
2017 Q2	$3.08M	Sell	27,743 -1,833	-6%	-$194K	0.02%	434
2017 Q1	$2.9M	Sell	29,576 -327	-1%	-$31.2K	0.02%	441
2016 Q4	$2.75M	Sell	29,903 -583	-2%	-$50.2K	0.02%	456
2016 Q3	$2.58M	Sell	30,486 -1,972	-6%	-$166K	0.02%	465
2016 Q2	$2.64M	Sell	32,458 -2,042	-6%	-$155K	0.02%	460
2016 Q1	$2.46M	Sell	34,500 -4,814	-12%	-$323K	0.02%	486
2015 Q4	$2.8M	Buy	39,314 +3,408	+9%	+$229K	0.02%	458
2015 Q3	$2.21M	Buy	35,906 +9,180	+34%	+$642K	0.02%	531
2015 Q2	$1.94M	Buy	26,726 +1,709	+7%	+$126K	0.01%	638
2015 Q1	$1.92M	Buy	25,017 +10,573	+73%	+$757K	0.01%	636
2014 Q4	$968K	Sell	14,444 -2,931	-17%	-$185K	0.01%	876
2014 Q3	$1.05M	Buy	17,375 +17,075	+5,692%	+$1.05M	0.01%	863
2014 Q2	$18K	Hold	300	–	–	﹤0.01%	862
2014 Q1	$17K	Hold	300	–	–	﹤0.01%	870
2013 Q4	$16K	Hold	300	–	–	﹤0.01%	847
2013 Q3	$19K	Sell	300 -2,000	-87%	-$120K	﹤0.01%	757
2013 Q2	$139K	Buy	+2,300	New	+$137K	0.01%	442

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

M&T Bank's DGX Position: Q1 2026 in Review

M&T Bank reduced its Quest Diagnostics (DGX) stake by 12% in Q1 2026, selling an estimated $345K and leaving 13,200 shares worth $2.59M. The position accounts for 0.01% of the portfolio, ranked #537.

M&T Bank first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.51M in Q4 2021. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

M&T Bank held 13,200 shares of Quest Diagnostics worth $2.59M as of Q1 2026.
M&T Bank sold 1,774 Quest Diagnostics shares in Q1 2026, an estimated $345K.
Quest Diagnostics made up 0.01% of M&T Bank's portfolio in Q1 2026, its #537 holding.
M&T Bank first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
M&T Bank's Quest Diagnostics position peaked at $5.51M in Q4 2021.
1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.